EP 1140208 A1 20011010 - PHARMACEUTICAL COMPOSITIONS COMPRISING IMMORTALISED ENDOTHELIAL CELLS
Title (en)
PHARMACEUTICAL COMPOSITIONS COMPRISING IMMORTALISED ENDOTHELIAL CELLS
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ENTHALTEND IMMORTALIZIERTE ENDOTHELIAZELLINIEN
Title (fr)
COMPOSITIONS PHARMACEUTIQUES COMPRENANT DES CELLULES ENDOTHELIALES IMMORTALISEES
Publication
Application
Priority
- FR 9902965 W 19991130
- FR 9816145 A 19981221
Abstract (en)
[origin: FR2787464A1] Pharmaceutical composition (A) for diagnosis and/or treatment of angiogenesis sources (AS) by systemic administration comprises mammalian endothelial cells (EC) which have been immortalized and optionally also include an active agent (I). An Independent claim is also included for detection or diagnosis of AS by injecting A into the blood stream then either imaging all or part of the subject or taking a body fluid sample for analysis.
IPC 1-7
IPC 8 full level
G01N 33/50 (2006.01); A61K 35/12 (2015.01); A61K 35/44 (2015.01); A61K 45/00 (2006.01); A61K 47/48 (2006.01); A61K 48/00 (2006.01); A61K 49/00 (2006.01); A61P 9/10 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 37/06 (2006.01)
CPC (source: EP)
A61K 48/00 (2013.01); A61K 49/0002 (2013.01); A61P 9/10 (2018.01); A61P 27/00 (2018.01); A61P 29/00 (2018.01); A61P 35/00 (2018.01); A61P 37/06 (2018.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
FR 2787464 A1 20000623; FR 2787464 B1 20030110; AU 1392400 A 20000712; AU 777526 B2 20041021; CA 2355879 A1 20000629; EP 1140208 A1 20011010; JP 2002532567 A 20021002; WO 0037112 A1 20000629
DOCDB simple family (application)
FR 9816145 A 19981221; AU 1392400 A 19991130; CA 2355879 A 19991130; EP 99973474 A 19991130; FR 9902965 W 19991130; JP 2000589222 A 19991130